Surgery Partners, Inc.

NASDAQ:SGRY

Medical - Care Facilities

Healthcare
$26.96 +0.39%

+$0.06 today

Market cap
$3.53B
Beta
1.95
P/E (TTM)
-24.1
EPS (TTM)
-$0.59
52W Low $11.41High $24.10

Volume 3.24M

Average 1.36M

SGRY Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

Surgery Partners, Inc.NASDAQ: SGRY

Depreciation & Amortization · Q3 FY2026 · quarter ended Sep 2026

Depreciation & amortization grows, but more slowly than its trailing trend

Q3 FY2026 depreciation & amortization of $39.6M rose 0.3% year over year, behind the +18.2% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 0.8% from the prior quarter. Over 3 fiscal years it compounded at +15.3% a year.

Context

  • Depreciation & amortization amounted to 5.3% of revenue in FY2025, up 0.4 pp from a year earlier.
  • Depreciation & amortization increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +0.3% toward the trailing-twelve-month pace of +18.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$39.6M+0.8% QoQ
Last fiscal yearDec 2025
$176M+15.3% YoY
LTMSep 2026
$177.3M+18.2% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.3%——
1 year+15.3%——
3-year CAGR+15.3%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
176M USD
Year-over-year change
+15.3%
4-year CAGR
+15.5%

Depreciation & Amortization vs competitors

How SGRY compares with its peers on the latest reported figures

  • SGRY's LTM Sep 2026 depreciation & amortization of $177.3M is the 5th highest of the 7 companies compared; the peer median is $687.58M.
  • Its year-over-year change of +18.2% is the 2nd highest of 7, against a peer median of +8.4%.
  • Depreciation & amortization amounts to 5.3% of revenue for SGRY, versus a peer median of 3.5%.
SGRY Competitors Peer median
Depreciation & Amortization for SGRY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HCAHCA Healthcare, Inc.LTM Jun 2026$3.67B +7.4%+5.9%4.7%
THCTenet Healthcare CorporationLTM Jun 2026$893M +9.4%+0.9%4.1%
CYHCommunity Health Systems, Inc.LTM Mar 2026$734M +85.4%-1.7%3.4%
UHSUniversal Health Services, Inc.LTM Jun 2026$641.16M +7.5%+2.1%3.5%
SGRYSurgery Partners, Inc.LTM Sep 2026$177.3M +18.2%+15.3%5.3%
ARDTArdent Health Partners, LLCLTM Mar 2026$162.49M +10.4%+4.1%2.5%
NUTXNutex Health, Inc.LTM Mar 2026$20.93M +5.3%+16.1%2.4%
Peer median (excluding SGRY) $687.58M+8.4%+3.1%3.5%

Competitors are the stored peer set for SGRY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.23B2.54B2.74B3.11B3.31B
Cost of Revenue1.73B1.96B2.1B2.37B2.54B
Gross Profit491.4M574.9M647.5M745.6M765M
Gross Margin22.1%22.6%23.6%23.9%23.1%
Research & Development00000
Selling, General & Admin104M102.2M120.9M138.7M522.7M
Operating Expenses189.2M229.7M319.5M396.8M375.5M
Depreciation & Amortization98.8M114.8M118.1M152.6M176M
EBITDA401M460M446.1M501.4M565.5M
EBITDA Margin18.0%18.1%16.3%16.1%17.1%
Operating Income302.2M345.2M328M348.8M389.5M
Operating Margin13.6%13.6%12.0%11.2%11.8%
Interest Income00000
Interest Expense221M234.9M193M201.7M272.6M
Other Income / Expenses(221M)(234.9M)(193M)(201.7M)(272.6M)
Income Before Tax81.2M110.3M135M147.1M116.9M
Pre-Tax Margin3.6%4.3%4.9%4.7%3.5%
Income Tax Expense10.5M23.3M(300K)134.6M18M
Net Income(70.9M)(54.6M)(11.9M)(168.1M)(77.9M)
Net Margin-3.2%-2.2%-0.4%-5.4%-2.4%
EPS (Basic)(1.12)(0.59)(0.09)(1.33)(0.61)
EPS (Diluted)(1.12)(0.59)(0.09)(1.33)(0.61)
Weighted Avg Shares72.43M91.95M125.61M126.12M127.21M
Weighted Avg Shares (Diluted)72.43M91.95M125.61M126.12M127.21M

Surgery Partners, Inc.

NASDAQ:SGRY

Intrinsic Alpha fair value

Locked

Current Price

$26.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.